The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biotechnological Drugs Market Research Report 2025
Synopsis
Biotechnological Drugs, also known as biologics, are pharmaceutical products derived from living organisms using biotechnology techniques. These drugs can include vaccines, monoclonal antibodies, and gene therapies.
The global Biotechnological Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biotechnological Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biotechnological Drugs.
Report Scope
The Biotechnological Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biotechnological Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biotechnological Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
3SBIO
Anhui Anke Biotechnology
Beijing SL Pharmaceutical
Biotech Pharmaceutical
Cadila Healthcare
Celgen Biopharma
Celltrion
Dr Reddy’s
GeneScience Pharmaceuticals
Hisun Pharma
Jiangsu Sihuan Bioengineering
Novartis (Sandoz)
Pfizer (Hospira)
Shanghai Lansheng Guojian Pharmaceutical
Shenzhen Neptunus Interlong Bio-Technique
Tonghua Dongbao Pharmaceutical
Torrent Pharmaceuticals
Segment by Type
Genetically Engineered Drugs
Therapeutic Monoclonal Antibody Drugs
Gene Therapy and Nucleic Acid Drugs
Genetically Engineered Vaccines
Other
Segment by Application
Tumor
Autoimmune Disease
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biotechnological Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Biotechnological Drugs, also known as biologics, are pharmaceutical products derived from living organisms using biotechnology techniques. These drugs can include vaccines, monoclonal antibodies, and gene therapies.
The global Biotechnological Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biotechnological Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biotechnological Drugs.
Report Scope
The Biotechnological Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biotechnological Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biotechnological Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
3SBIO
Anhui Anke Biotechnology
Beijing SL Pharmaceutical
Biotech Pharmaceutical
Cadila Healthcare
Celgen Biopharma
Celltrion
Dr Reddy’s
GeneScience Pharmaceuticals
Hisun Pharma
Jiangsu Sihuan Bioengineering
Novartis (Sandoz)
Pfizer (Hospira)
Shanghai Lansheng Guojian Pharmaceutical
Shenzhen Neptunus Interlong Bio-Technique
Tonghua Dongbao Pharmaceutical
Torrent Pharmaceuticals
Segment by Type
Genetically Engineered Drugs
Therapeutic Monoclonal Antibody Drugs
Gene Therapy and Nucleic Acid Drugs
Genetically Engineered Vaccines
Other
Segment by Application
Tumor
Autoimmune Disease
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biotechnological Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biotechnological Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Genetically Engineered Drugs
1.2.3 Therapeutic Monoclonal Antibody Drugs
1.2.4 Gene Therapy and Nucleic Acid Drugs
1.2.5 Genetically Engineered Vaccines
1.2.6 Other
1.3 Market by Application
1.3.1 Global Biotechnological Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Tumor
1.3.3 Autoimmune Disease
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biotechnological Drugs Market Perspective (2019-2030)
2.2 Biotechnological Drugs Growth Trends by Region
2.2.1 Global Biotechnological Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biotechnological Drugs Historic Market Size by Region (2019-2024)
2.2.3 Biotechnological Drugs Forecasted Market Size by Region (2025-2030)
2.3 Biotechnological Drugs Market Dynamics
2.3.1 Biotechnological Drugs Industry Trends
2.3.2 Biotechnological Drugs Market Drivers
2.3.3 Biotechnological Drugs Market Challenges
2.3.4 Biotechnological Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biotechnological Drugs Players by Revenue
3.1.1 Global Top Biotechnological Drugs Players by Revenue (2019-2024)
3.1.2 Global Biotechnological Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Biotechnological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biotechnological Drugs Revenue
3.4 Global Biotechnological Drugs Market Concentration Ratio
3.4.1 Global Biotechnological Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biotechnological Drugs Revenue in 2023
3.5 Biotechnological Drugs Key Players Head office and Area Served
3.6 Key Players Biotechnological Drugs Product Solution and Service
3.7 Date of Enter into Biotechnological Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biotechnological Drugs Breakdown Data by Type
4.1 Global Biotechnological Drugs Historic Market Size by Type (2019-2024)
4.2 Global Biotechnological Drugs Forecasted Market Size by Type (2025-2030)
5 Biotechnological Drugs Breakdown Data by Application
5.1 Global Biotechnological Drugs Historic Market Size by Application (2019-2024)
5.2 Global Biotechnological Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biotechnological Drugs Market Size (2019-2030)
6.2 North America Biotechnological Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biotechnological Drugs Market Size by Country (2019-2024)
6.4 North America Biotechnological Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biotechnological Drugs Market Size (2019-2030)
7.2 Europe Biotechnological Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biotechnological Drugs Market Size by Country (2019-2024)
7.4 Europe Biotechnological Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biotechnological Drugs Market Size (2019-2030)
8.2 Asia-Pacific Biotechnological Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biotechnological Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Biotechnological Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biotechnological Drugs Market Size (2019-2030)
9.2 Latin America Biotechnological Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biotechnological Drugs Market Size by Country (2019-2024)
9.4 Latin America Biotechnological Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biotechnological Drugs Market Size (2019-2030)
10.2 Middle East & Africa Biotechnological Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biotechnological Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Biotechnological Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 3SBIO
11.1.1 3SBIO Company Detail
11.1.2 3SBIO Business Overview
11.1.3 3SBIO Biotechnological Drugs Introduction
11.1.4 3SBIO Revenue in Biotechnological Drugs Business (2019-2024)
11.1.5 3SBIO Recent Development
11.2 Anhui Anke Biotechnology
11.2.1 Anhui Anke Biotechnology Company Detail
11.2.2 Anhui Anke Biotechnology Business Overview
11.2.3 Anhui Anke Biotechnology Biotechnological Drugs Introduction
11.2.4 Anhui Anke Biotechnology Revenue in Biotechnological Drugs Business (2019-2024)
11.2.5 Anhui Anke Biotechnology Recent Development
11.3 Beijing SL Pharmaceutical
11.3.1 Beijing SL Pharmaceutical Company Detail
11.3.2 Beijing SL Pharmaceutical Business Overview
11.3.3 Beijing SL Pharmaceutical Biotechnological Drugs Introduction
11.3.4 Beijing SL Pharmaceutical Revenue in Biotechnological Drugs Business (2019-2024)
11.3.5 Beijing SL Pharmaceutical Recent Development
11.4 Biotech Pharmaceutical
11.4.1 Biotech Pharmaceutical Company Detail
11.4.2 Biotech Pharmaceutical Business Overview
11.4.3 Biotech Pharmaceutical Biotechnological Drugs Introduction
11.4.4 Biotech Pharmaceutical Revenue in Biotechnological Drugs Business (2019-2024)
11.4.5 Biotech Pharmaceutical Recent Development
11.5 Cadila Healthcare
11.5.1 Cadila Healthcare Company Detail
11.5.2 Cadila Healthcare Business Overview
11.5.3 Cadila Healthcare Biotechnological Drugs Introduction
11.5.4 Cadila Healthcare Revenue in Biotechnological Drugs Business (2019-2024)
11.5.5 Cadila Healthcare Recent Development
11.6 Celgen Biopharma
11.6.1 Celgen Biopharma Company Detail
11.6.2 Celgen Biopharma Business Overview
11.6.3 Celgen Biopharma Biotechnological Drugs Introduction
11.6.4 Celgen Biopharma Revenue in Biotechnological Drugs Business (2019-2024)
11.6.5 Celgen Biopharma Recent Development
11.7 Celltrion
11.7.1 Celltrion Company Detail
11.7.2 Celltrion Business Overview
11.7.3 Celltrion Biotechnological Drugs Introduction
11.7.4 Celltrion Revenue in Biotechnological Drugs Business (2019-2024)
11.7.5 Celltrion Recent Development
11.8 Dr Reddy’s
11.8.1 Dr Reddy’s Company Detail
11.8.2 Dr Reddy’s Business Overview
11.8.3 Dr Reddy’s Biotechnological Drugs Introduction
11.8.4 Dr Reddy’s Revenue in Biotechnological Drugs Business (2019-2024)
11.8.5 Dr Reddy’s Recent Development
11.9 GeneScience Pharmaceuticals
11.9.1 GeneScience Pharmaceuticals Company Detail
11.9.2 GeneScience Pharmaceuticals Business Overview
11.9.3 GeneScience Pharmaceuticals Biotechnological Drugs Introduction
11.9.4 GeneScience Pharmaceuticals Revenue in Biotechnological Drugs Business (2019-2024)
11.9.5 GeneScience Pharmaceuticals Recent Development
11.10 Hisun Pharma
11.10.1 Hisun Pharma Company Detail
11.10.2 Hisun Pharma Business Overview
11.10.3 Hisun Pharma Biotechnological Drugs Introduction
11.10.4 Hisun Pharma Revenue in Biotechnological Drugs Business (2019-2024)
11.10.5 Hisun Pharma Recent Development
11.11 Jiangsu Sihuan Bioengineering
11.11.1 Jiangsu Sihuan Bioengineering Company Detail
11.11.2 Jiangsu Sihuan Bioengineering Business Overview
11.11.3 Jiangsu Sihuan Bioengineering Biotechnological Drugs Introduction
11.11.4 Jiangsu Sihuan Bioengineering Revenue in Biotechnological Drugs Business (2019-2024)
11.11.5 Jiangsu Sihuan Bioengineering Recent Development
11.12 Novartis (Sandoz)
11.12.1 Novartis (Sandoz) Company Detail
11.12.2 Novartis (Sandoz) Business Overview
11.12.3 Novartis (Sandoz) Biotechnological Drugs Introduction
11.12.4 Novartis (Sandoz) Revenue in Biotechnological Drugs Business (2019-2024)
11.12.5 Novartis (Sandoz) Recent Development
11.13 Pfizer (Hospira)
11.13.1 Pfizer (Hospira) Company Detail
11.13.2 Pfizer (Hospira) Business Overview
11.13.3 Pfizer (Hospira) Biotechnological Drugs Introduction
11.13.4 Pfizer (Hospira) Revenue in Biotechnological Drugs Business (2019-2024)
11.13.5 Pfizer (Hospira) Recent Development
11.14 Shanghai Lansheng Guojian Pharmaceutical
11.14.1 Shanghai Lansheng Guojian Pharmaceutical Company Detail
11.14.2 Shanghai Lansheng Guojian Pharmaceutical Business Overview
11.14.3 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Introduction
11.14.4 Shanghai Lansheng Guojian Pharmaceutical Revenue in Biotechnological Drugs Business (2019-2024)
11.14.5 Shanghai Lansheng Guojian Pharmaceutical Recent Development
11.15 Shenzhen Neptunus Interlong Bio-Technique
11.15.1 Shenzhen Neptunus Interlong Bio-Technique Company Detail
11.15.2 Shenzhen Neptunus Interlong Bio-Technique Business Overview
11.15.3 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Introduction
11.15.4 Shenzhen Neptunus Interlong Bio-Technique Revenue in Biotechnological Drugs Business (2019-2024)
11.15.5 Shenzhen Neptunus Interlong Bio-Technique Recent Development
11.16 Tonghua Dongbao Pharmaceutical
11.16.1 Tonghua Dongbao Pharmaceutical Company Detail
11.16.2 Tonghua Dongbao Pharmaceutical Business Overview
11.16.3 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Introduction
11.16.4 Tonghua Dongbao Pharmaceutical Revenue in Biotechnological Drugs Business (2019-2024)
11.16.5 Tonghua Dongbao Pharmaceutical Recent Development
11.17 Torrent Pharmaceuticals
11.17.1 Torrent Pharmaceuticals Company Detail
11.17.2 Torrent Pharmaceuticals Business Overview
11.17.3 Torrent Pharmaceuticals Biotechnological Drugs Introduction
11.17.4 Torrent Pharmaceuticals Revenue in Biotechnological Drugs Business (2019-2024)
11.17.5 Torrent Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Biotechnological Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Genetically Engineered Drugs
Table 3. Key Players of Therapeutic Monoclonal Antibody Drugs
Table 4. Key Players of Gene Therapy and Nucleic Acid Drugs
Table 5. Key Players of Genetically Engineered Vaccines
Table 6. Key Players of Other
Table 7. Global Biotechnological Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Biotechnological Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Biotechnological Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Biotechnological Drugs Market Share by Region (2019-2024)
Table 11. Global Biotechnological Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Biotechnological Drugs Market Share by Region (2025-2030)
Table 13. Biotechnological Drugs Market Trends
Table 14. Biotechnological Drugs Market Drivers
Table 15. Biotechnological Drugs Market Challenges
Table 16. Biotechnological Drugs Market Restraints
Table 17. Global Biotechnological Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Biotechnological Drugs Market Share by Players (2019-2024)
Table 19. Global Top Biotechnological Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotechnological Drugs as of 2023)
Table 20. Ranking of Global Top Biotechnological Drugs Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Biotechnological Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Biotechnological Drugs Product Solution and Service
Table 24. Date of Enter into Biotechnological Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Biotechnological Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Biotechnological Drugs Revenue Market Share by Type (2019-2024)
Table 28. Global Biotechnological Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Biotechnological Drugs Revenue Market Share by Type (2025-2030)
Table 30. Global Biotechnological Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Biotechnological Drugs Revenue Market Share by Application (2019-2024)
Table 32. Global Biotechnological Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Biotechnological Drugs Revenue Market Share by Application (2025-2030)
Table 34. North America Biotechnological Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Biotechnological Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Biotechnological Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Biotechnological Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Biotechnological Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Biotechnological Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Biotechnological Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Biotechnological Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Biotechnological Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Biotechnological Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Biotechnological Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Biotechnological Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Biotechnological Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Biotechnological Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Biotechnological Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 49. 3SBIO Company Detail
Table 50. 3SBIO Business Overview
Table 51. 3SBIO Biotechnological Drugs Product
Table 52. 3SBIO Revenue in Biotechnological Drugs Business (2019-2024) & (US$ Million)
Table 53. 3SBIO Recent Development
Table 54. Anhui Anke Biotechnology Company Detail
Table 55. Anhui Anke Biotechnology Business Overview
Table 56. Anhui Anke Biotechnology Biotechnological Drugs Product
Table 57. Anhui Anke Biotechnology Revenue in Biotechnological Drugs Business (2019-2024) & (US$ Million)
Table 58. Anhui Anke Biotechnology Recent Development
Table 59. Beijing SL Pharmaceutical Company Detail
Table 60. Beijing SL Pharmaceutical Business Overview
Table 61. Beijing SL Pharmaceutical Biotechnological Drugs Product
Table 62. Beijing SL Pharmaceutical Revenue in Biotechnological Drugs Business (2019-2024) & (US$ Million)
Table 63. Beijing SL Pharmaceutical Recent Development
Table 64. Biotech Pharmaceutical Company Detail
Table 65. Biotech Pharmaceutical Business Overview
Table 66. Biotech Pharmaceutical Biotechnological Drugs Product
Table 67. Biotech Pharmaceutical Revenue in Biotechnological Drugs Business (2019-2024) & (US$ Million)
Table 68. Biotech Pharmaceutical Recent Development
Table 69. Cadila Healthcare Company Detail
Table 70. Cadila Healthcare Business Overview
Table 71. Cadila Healthcare Biotechnological Drugs Product
Table 72. Cadila Healthcare Revenue in Biotechnological Drugs Business (2019-2024) & (US$ Million)
Table 73. Cadila Healthcare Recent Development
Table 74. Celgen Biopharma Company Detail
Table 75. Celgen Biopharma Business Overview
Table 76. Celgen Biopharma Biotechnological Drugs Product
Table 77. Celgen Biopharma Revenue in Biotechnological Drugs Business (2019-2024) & (US$ Million)
Table 78. Celgen Biopharma Recent Development
Table 79. Celltrion Company Detail
Table 80. Celltrion Business Overview
Table 81. Celltrion Biotechnological Drugs Product
Table 82. Celltrion Revenue in Biotechnological Drugs Business (2019-2024) & (US$ Million)
Table 83. Celltrion Recent Development
Table 84. Dr Reddy’s Company Detail
Table 85. Dr Reddy’s Business Overview
Table 86. Dr Reddy’s Biotechnological Drugs Product
Table 87. Dr Reddy’s Revenue in Biotechnological Drugs Business (2019-2024) & (US$ Million)
Table 88. Dr Reddy’s Recent Development
Table 89. GeneScience Pharmaceuticals Company Detail
Table 90. GeneScience Pharmaceuticals Business Overview
Table 91. GeneScience Pharmaceuticals Biotechnological Drugs Product
Table 92. GeneScience Pharmaceuticals Revenue in Biotechnological Drugs Business (2019-2024) & (US$ Million)
Table 93. GeneScience Pharmaceuticals Recent Development
Table 94. Hisun Pharma Company Detail
Table 95. Hisun Pharma Business Overview
Table 96. Hisun Pharma Biotechnological Drugs Product
Table 97. Hisun Pharma Revenue in Biotechnological Drugs Business (2019-2024) & (US$ Million)
Table 98. Hisun Pharma Recent Development
Table 99. Jiangsu Sihuan Bioengineering Company Detail
Table 100. Jiangsu Sihuan Bioengineering Business Overview
Table 101. Jiangsu Sihuan Bioengineering Biotechnological Drugs Product
Table 102. Jiangsu Sihuan Bioengineering Revenue in Biotechnological Drugs Business (2019-2024) & (US$ Million)
Table 103. Jiangsu Sihuan Bioengineering Recent Development
Table 104. Novartis (Sandoz) Company Detail
Table 105. Novartis (Sandoz) Business Overview
Table 106. Novartis (Sandoz) Biotechnological Drugs Product
Table 107. Novartis (Sandoz) Revenue in Biotechnological Drugs Business (2019-2024) & (US$ Million)
Table 108. Novartis (Sandoz) Recent Development
Table 109. Pfizer (Hospira) Company Detail
Table 110. Pfizer (Hospira) Business Overview
Table 111. Pfizer (Hospira) Biotechnological Drugs Product
Table 112. Pfizer (Hospira) Revenue in Biotechnological Drugs Business (2019-2024) & (US$ Million)
Table 113. Pfizer (Hospira) Recent Development
Table 114. Shanghai Lansheng Guojian Pharmaceutical Company Detail
Table 115. Shanghai Lansheng Guojian Pharmaceutical Business Overview
Table 116. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Product
Table 117. Shanghai Lansheng Guojian Pharmaceutical Revenue in Biotechnological Drugs Business (2019-2024) & (US$ Million)
Table 118. Shanghai Lansheng Guojian Pharmaceutical Recent Development
Table 119. Shenzhen Neptunus Interlong Bio-Technique Company Detail
Table 120. Shenzhen Neptunus Interlong Bio-Technique Business Overview
Table 121. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Product
Table 122. Shenzhen Neptunus Interlong Bio-Technique Revenue in Biotechnological Drugs Business (2019-2024) & (US$ Million)
Table 123. Shenzhen Neptunus Interlong Bio-Technique Recent Development
Table 124. Tonghua Dongbao Pharmaceutical Company Detail
Table 125. Tonghua Dongbao Pharmaceutical Business Overview
Table 126. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Product
Table 127. Tonghua Dongbao Pharmaceutical Revenue in Biotechnological Drugs Business (2019-2024) & (US$ Million)
Table 128. Tonghua Dongbao Pharmaceutical Recent Development
Table 129. Torrent Pharmaceuticals Company Detail
Table 130. Torrent Pharmaceuticals Business Overview
Table 131. Torrent Pharmaceuticals Biotechnological Drugs Product
Table 132. Torrent Pharmaceuticals Revenue in Biotechnological Drugs Business (2019-2024) & (US$ Million)
Table 133. Torrent Pharmaceuticals Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biotechnological Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Biotechnological Drugs Market Share by Type: 2023 VS 2030
Figure 3. Genetically Engineered Drugs Features
Figure 4. Therapeutic Monoclonal Antibody Drugs Features
Figure 5. Gene Therapy and Nucleic Acid Drugs Features
Figure 6. Genetically Engineered Vaccines Features
Figure 7. Other Features
Figure 8. Global Biotechnological Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Biotechnological Drugs Market Share by Application: 2023 VS 2030
Figure 10. Tumor Case Studies
Figure 11. Autoimmune Disease Case Studies
Figure 12. Other Case Studies
Figure 13. Biotechnological Drugs Report Years Considered
Figure 14. Global Biotechnological Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Biotechnological Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Biotechnological Drugs Market Share by Region: 2023 VS 2030
Figure 17. Global Biotechnological Drugs Market Share by Players in 2023
Figure 18. Global Top Biotechnological Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotechnological Drugs as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Biotechnological Drugs Revenue in 2023
Figure 20. North America Biotechnological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Biotechnological Drugs Market Share by Country (2019-2030)
Figure 22. United States Biotechnological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Biotechnological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Biotechnological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Biotechnological Drugs Market Share by Country (2019-2030)
Figure 26. Germany Biotechnological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Biotechnological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Biotechnological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Biotechnological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Biotechnological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Biotechnological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Biotechnological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Biotechnological Drugs Market Share by Region (2019-2030)
Figure 34. China Biotechnological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Biotechnological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Biotechnological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Biotechnological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Biotechnological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Biotechnological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Biotechnological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Biotechnological Drugs Market Share by Country (2019-2030)
Figure 42. Mexico Biotechnological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Biotechnological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Biotechnological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Biotechnological Drugs Market Share by Country (2019-2030)
Figure 46. Turkey Biotechnological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Biotechnological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. 3SBIO Revenue Growth Rate in Biotechnological Drugs Business (2019-2024)
Figure 49. Anhui Anke Biotechnology Revenue Growth Rate in Biotechnological Drugs Business (2019-2024)
Figure 50. Beijing SL Pharmaceutical Revenue Growth Rate in Biotechnological Drugs Business (2019-2024)
Figure 51. Biotech Pharmaceutical Revenue Growth Rate in Biotechnological Drugs Business (2019-2024)
Figure 52. Cadila Healthcare Revenue Growth Rate in Biotechnological Drugs Business (2019-2024)
Figure 53. Celgen Biopharma Revenue Growth Rate in Biotechnological Drugs Business (2019-2024)
Figure 54. Celltrion Revenue Growth Rate in Biotechnological Drugs Business (2019-2024)
Figure 55. Dr Reddy’s Revenue Growth Rate in Biotechnological Drugs Business (2019-2024)
Figure 56. GeneScience Pharmaceuticals Revenue Growth Rate in Biotechnological Drugs Business (2019-2024)
Figure 57. Hisun Pharma Revenue Growth Rate in Biotechnological Drugs Business (2019-2024)
Figure 58. Jiangsu Sihuan Bioengineering Revenue Growth Rate in Biotechnological Drugs Business (2019-2024)
Figure 59. Novartis (Sandoz) Revenue Growth Rate in Biotechnological Drugs Business (2019-2024)
Figure 60. Pfizer (Hospira) Revenue Growth Rate in Biotechnological Drugs Business (2019-2024)
Figure 61. Shanghai Lansheng Guojian Pharmaceutical Revenue Growth Rate in Biotechnological Drugs Business (2019-2024)
Figure 62. Shenzhen Neptunus Interlong Bio-Technique Revenue Growth Rate in Biotechnological Drugs Business (2019-2024)
Figure 63. Tonghua Dongbao Pharmaceutical Revenue Growth Rate in Biotechnological Drugs Business (2019-2024)
Figure 64. Torrent Pharmaceuticals Revenue Growth Rate in Biotechnological Drugs Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
